Terns Pharmaceuticals logo

Terns Pharmaceuticals share price today

(TERN)

Terns Pharmaceuticals share price is $5.8 & ₹494.15 as on 25 Dec 2024, 2.30 'hrs' IST

$5.8

-0.13

(-2.19%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Terns Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Terns Pharmaceuticals from India. Also see the sentimental analysis on Indian investors investing in Terns Pharmaceuticals. Get details on the Indian mutual funds that are investing in Terns Pharmaceuticals. Get Analyst recommendations and forecasts along with all the Terns Pharmaceuticals's financials.

Terns Pharmaceuticals share price movements

  • Today's Low: $5.69
    Today's High: $5.85

    Day's Volatility :2.74%

  • 52 Weeks Low: $4.32
    52 Weeks High: $11.40

    52 Weeks Volatility :62.11%

Terns Pharmaceuticals Returns

PeriodTerns Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
-34.46%
-9.0%
0.0%
6 Months
-18.42%
-4.6%
0.0%
1 Year
-13.43%
3.0%
0.0%
3 Years
-10.08%
0.0%
-21.1%

Terns Pharmaceuticals Key Statistics

in dollars & INR

Previous Close
$5.93
Open
$5.93
Today's High
$5.85
Today's Low
$5.69
Market Capitalization
$492.6M
Today's Volume
$433.8K
52 Week High
$11.4
52 Week Low
$4.32
Revenue TTM
$1000.0K
EBITDA
$-99.7M
Earnings Per Share (EPS)
$-1.18
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-28.28%

How to invest in Terns Pharmaceuticals from India?

It is very easy for Indian residents to invest directly in Terns Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Terns Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Terns Pharmaceuticals or TERN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Terns Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Terns Pharmaceuticals shares which would translate to 0.147 fractional shares of Terns Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Terns Pharmaceuticals, in just a few clicks!

Returns in Terns Pharmaceuticals for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Terns Pharmaceuticals investment value today

Current value as on today

₹88,806

Returns

₹11,194

(-11.19%)

Returns from Terns Pharmaceuticals Stock

₹13,433 (-13.43%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Terns Pharmaceuticals

-14%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Terns Pharmaceuticals on INDmoney from India has reduced in the last 30 days as on Dec 26, 2024. -14% less investors are searching Terns Pharmaceuticals in the last 30 days versus the previous period.

Global Institutional Holdings in Terns Pharmaceuticals

  • Orbimed Advisors, LLC

    8.90%

  • Vivo Capital, LLC

    8.12%

  • Soleus Capital Management, L.P.

    7.33%

  • Deep Track Capital, LP

    6.57%

  • BlackRock Inc

    4.85%

  • Citadel Advisors Llc

    4.32%

Analyst Recommendation on Terns Pharmaceuticals

Buy

    78%Buy

    21%Hold

    0%Sell

Based on 14 Wall street analysts offering stock ratings for Terns Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 14 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
11
Hold
3
3
3
Sell
0
0
0

Analyst Forecast on Terns Pharmaceuticals

What analysts predicted

Upside of 228.66%

Current:

$5.80

Target:

$19.06

Insights on Terns Pharmaceuticals

  • Price Movement

    In the last 7 days, TERN stock has moved down by -4.1%
  • TERN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 39.2%
  • TERN vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 34.9%
  • Price to Sales

    ForTERN every $1 of sales, investors are willing to pay $165.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Terns Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Terns Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Terns Pharmaceuticals Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Terns Pharmaceuticals Inc
-1.36%
-18.42%
-13.43%
-10.08%
-68.46%
Regeneron Pharmaceuticals, Inc.
-5.12%
-32.01%
-18.29%
12.56%
91.19%
Biontech Se
-3.72%
41.99%
6.11%
-55.22%
226.93%
Alnylam Pharmaceuticals, Inc.
-3.99%
-1.52%
23.75%
50.98%
112.09%
Vertex Pharmaceuticals Incorporated
-12.61%
-13.61%
0.03%
83.58%
86.41%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Terns Pharmaceuticals Inc
NA
NA
NA
-1.19
-0.28
-0.19
NA
4.29
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Terns Pharmaceuticals Inc
Buy
$492.6M
-68.46%
NA
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
91.19%
17.67
33.61%
Biontech Se
Buy
$27.4B
226.93%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.4B
112.09%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$105.1B
86.41%
32.84
-4.51%

About Terns Pharmaceuticals

terns pharmaceuticals is a global biopharmaceutical company committed to discovering and developing molecularly-targeted, oral, small molecule drugs to treat liver diseases and cancers. the company combines expertise in disease biology and medicinal chemistry with a capital-efficient drug discovery model and extensive clinical development capabilities in china to advance its growing pipeline of drugs that are optimized against clinically-validated targets. based in san mateo, california and shanghai, terns is focused on bringing forward innovative therapeutic candidates with the potential to address significant unmet medical needs in china and globally.
Organization
Terns Pharmaceuticals
Employees
66
CEO
Dr. Mark Joseph Vignola Ph.D.
Industry
Services

Management People of Terns Pharmaceuticals

NameTitle
Dr. Mark Joseph Vignola Ph.D.
CFO & Treasurer
Ms. Amy L. Burroughs M.B.A.
CEO & Director
Ms. Elona Kogan Esq., J.D.
Chief Legal Officer
Dr. Jeffrey R. Jasper Ph.D.
Senior Vice President of Research
Dr. Emil T. Kuriakose M.D.
Chief Medical Officer
Ms. Melita Sun Jung
Chief Business Officer
Mr. Scott Harris
Chief Development Officer
Ms. Debra Sieminski
Senior Vice President of Medical Affairs
Mr. David Eric Strauss
VP of Finance & Controller

Important FAQs about investing in Terns Pharmaceuticals from India :

What is Terns Pharmaceuticals share price today?

Terns Pharmaceuticals share price today stands at $5.80, Open: $5.93 ; Previous Close: $5.93 ; High: $5.85 ; Low: $5.69 ; 52 Week High: $11.40 ; 52 Week Low: $4.32. The stock opens at $5.93, after a previous close of $5.93. The stock reached a daily high of $5.85 and a low of $5.69, with a 52-week high of $11.40 and a 52-week low of $4.32.

Can Indians buy Terns Pharmaceuticals shares?

Yes, Indians can invest in the Terns Pharmaceuticals (TERN) from India.

With INDmoney, you can buy Terns Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Terns Pharmaceuticals at zero transaction cost.

How can I buy Terns Pharmaceuticals shares from India?

It is very easy to buy Terns Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Terns Pharmaceuticals be purchased?

Yes, you can buy fractional shares of Terns Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Terns Pharmaceuticals stocks?

To start investing in Terns Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Terns Pharmaceuticals

Today’s highest price of Terns Pharmaceuticals (TERN) is $5.85.

Today’s lowest price of Terns Pharmaceuticals (TERN) is $5.69.

What is today's market capitalisation of Terns Pharmaceuticals

Today's market capitalisation of Terns Pharmaceuticals TERN is 492.6M

What is the 52 Week High and Low Range of Terns Pharmaceuticals

  • 52 Week High

    $11.40

  • 52 Week Low

    $4.32

What are the historical returns of Terns Pharmaceuticals?

  • 1 Month Returns

    -1.36%

  • 3 Months Returns

    -18.42%

  • 1 Year Returns

    -13.43%

  • 5 Years Returns

    -68.46%

Who is the Chief Executive Officer (CEO) of Terns Pharmaceuticals

Dr. Mark Joseph Vignola Ph.D. is the current Chief Executive Officer (CEO) of Terns Pharmaceuticals.